Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Cancer Chemotherapy and Pharmacology
|
August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel
S Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel
M M de las Alas, R D Christen, D P Gately, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
O Pagani, D Klingbiel, T Ruhstaller, et al.
British Journal of Cancer
|
August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer
|
December 24, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
ESMO Open
|
May 16, 2022
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
E Razis, M J Escudero, C Palmieri, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Cancer Chemotherapy and Pharmacology
|
August 24, 1999
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel
S Aebi, T W Schnider, G Los, et al.
Cancer Chemotherapy and Pharmacology
|
May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel
M M de las Alas, R D Christen, D P Gately, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99
O Pagani, D Klingbiel, T Ruhstaller, et al.
British Journal of Cancer
|
August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer
|
December 24, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
J Feilchenfeldt, Z Varga, M Siano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 13, 2021
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
G Jerusalem, S Farah, A Courtois, et al.
ESMO Open
|
May 16, 2022
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
E Razis, M J Escudero, C Palmieri, et al.
Page
of 8